chr3-184353297-A-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004366.6(CLCN2):c.1981T>C(p.Ser661Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,642 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S661T) has been classified as Likely benign.
Frequency
Consequence
NM_004366.6 missense
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy with mild cerebellar ataxia and white matter edemaInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- epilepsy, idiopathic generalized, susceptibility to, 11Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- familial hyperaldosteronism type IIInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000855  AC: 13AN: 152132Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.000103  AC: 26AN: 251298 AF XY:  0.0000736   show subpopulations 
GnomAD4 exome  AF:  0.0000253  AC: 37AN: 1461510Hom.:  1  Cov.: 36 AF XY:  0.0000289  AC XY: 21AN XY: 727096 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000855  AC: 13AN: 152132Hom.:  0  Cov.: 31 AF XY:  0.000121  AC XY: 9AN XY: 74312 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases    Uncertain:1 
The c.1981T>C (p.S661P) alteration is located in exon 17 (coding exon 17) of the CLCN2 gene. This alteration results from a T to C substitution at nucleotide position 1981, causing the serine (S) at amino acid position 661 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided    Uncertain:1 
This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 661 of the CLCN2 protein (p.Ser661Pro). This variant is present in population databases (rs115380062, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CLCN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2510168). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CLCN2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at